| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vivosim Labs, Inc. (VIVS) has 7 insiders with recent SEC Form 4 filings, including 2 buys and 1 sell. VIVS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 53.5K | $74.4K | - | |
| Other | 40.0K | $55.6K | - | |
| Other | 26.1K | $36.2K | - | |
| Dir | 20.7K | $28.8K | - | |
| Dir | 19.9K | $27.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2015 | Baltera Robert Jr. | Director | Sell | 6,000 | $4.03 | $24,193.20 | -4.2% | |
| Aug 13, 2015 | Glover James T | Director | Buy | 10,000 | $2.80 | $28,000.00 | New | |
| Aug 12, 2015 | Murphy Keith | Chairman, CEO And President | Buy | 20,000 | $2.56 | $51,188.00 | +0.3% |